Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)
The purpose of this combined retrospective and prospective chart review analysis is to investigate the safety, efficacy, and predictability obtained via Laser-Assisted In Situ Keratomileusis (LASIK) and Advanced Surface Ablation (ASA) over a wide range of refractive errors
The working hypothesis is that there will be no difference in clinical outcomes between patients treated with LASIK or ASA.
|Official Title:||A Combined Retrospective and Prospective Chart Review Analysis of Visual Outcomes Following Excimer Laser Vision Correction|
- Visual Acuity [ Time Frame: 1 day, 1W, 1M, 3M, 6M, 9M, 12M ] [ Designated as safety issue: No ]
|Study Start Date:||February 2007|
|Estimated Study Completion Date:||December 2020|
Participants treated for Excimer laser vision correction using Advanced Surface Ablation (ASA).
Participants treated for Excimer laser vision correction using Laser-Assisted In Situ Keratomileusis (LASIK)
Excimer laser vision correction (LVC) is a widely used procedure to correct nearsightedness, farsightedness, and astigmatism by reshaping the surface of the eye (cornea). Laser-Assisted In Situ Keratomileusis (LASIK) and Advanced Surface Ablation (ASA) and are techniques currently used to prepare the cornea for Excimer LVC.
This review is intended to study whether LASIK is equal in visual outcome (null hypothesis), more effective (alternate hypothesis 1) or less effective (alternate hypothesis 2) than ASA in clinical outcome up to one year.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00778570
|Contact: George Mintsioulis, MDemail@example.com|
|Contact: W.Bruce Jackson, MDfirstname.lastname@example.org|
|University of Ottawa Eye Institute||Recruiting|
|Ottawa, Ontario, Canada, K1H 8L6|
|Contact: Gail Kayuk, BSc 613-737-8657 email@example.com|
|Principal Investigator: George Minstioulis, MD|
|Principal Investigator:||George Mintsioulis, MD||University of Ottawa Eye Institute|